News & Events
All actions of a drug can be understood better by understanding its direct interactions with proteins and the downstream effects of such interactions.
With DecryptM we have develo...
We are thrilled to congratulate the team around Bernard Haendler and Ekaterina Nevedomskaya on their recent publication of a multi-omics study on the proximal changes of androgen-s...
We are going to attend the Neuroscience2022 conference organized by the Society for Neuroscience. It will take place November 12-16 at San Diego Convention Center.Meet us there or ...
Meet us at BioEurope 2022 in Leipzig, October 24-26
Andreas Köpke will be representing us and can be found at the BioM Biotech joint booth #112.Try your luck or schedule a meeting...
We are looking for a Computational Biologist or Bioinformatician to join our team.
Find details here:
Bioinformatician (m/w/d) - 40 h per week, permanent position
We congratulate our co-founders and scientific advisors Bernhard Kuster and Mathias Wilhelm, their colleagues and collaborators for their recent publication on the draft of the mur...
In this large collaborative study with partners from DKFZ, Bayer and others, OmicScouts proteomic technologies helped to identify the target and mechanism of NCT02, a compound that...
Proteins are the most important biochemical function carriers. Their totality is called the proteome. Since the proteome of a cell or an organism is strongly influenced by external...
To strengthen our multidisciplinary team, we are looking for
Research Associate Biochemistry and Mass Spectrometry (MS)-based Proteomics
Computational Biologist or Bioinformati...
Together with our partners at the TUM Chair of Proteomics and Bioanalytics and the TUM Institute of Virology, we received grant funding of the Bayrische Forschungsstiftung for a pr...
Together with the Medical University of Vienna, TAmiRNA GmbH, and other partners, OmicScouts published a study on the combined used of proteomics and miRNomics as screening tools f...
OmicScouts will attend the premier partnering conference BIO-Europe. Take the opportunity and meet us in Hamburg between 11th and 13th November 2019. Meet our experts to discuss yo...
We are expanding our technology portfolio: We now support our drug discovery clients working in the field of event-driven pharmacology with our TurnoverScout™ technology.
As more ...
Join us at the the World Pharma Week in Boston. We will speak in the Chemical Biology and Target Validation track on June 18, 2019 about using proteomics and chemical proteomics to...
Join us at the the Neuro4D conference in Mainz, Germany. Our CEO, Hannes Hahne, will present work we have done together with our partner, Rodin Therapeutics, on complex-selective H...
We will be present at the the Proteomic Forum 2019 in Potsdam, the Annual meeting of the German Society for Proteome Research. If you would like to get in touch, feel free to drop ...
Dear colleagues,
We hope that you and your loved ones stay safe and healthy during these uncertain, challenging times. As COVID-19 continues to spread around the globe, and impact...
Numerous colleagues will be present at the EMBL conference "Proteomics in Cell Biology and Disease Mechanisms" 2019 in Heidelberg, Germany. If you would like to get in touch, feel ...
Our CEO, Hannes Hahne, will give a talk on "Proteomics for Target and Pathway Deconvolution" at the ELRIG Forum in Darmstadt, Germany. Feel free to drop us an e-mail (info(at)omics...
Together with the TU Munich, the Science for Life Laboratory at the KTH Royal Institute of Technology in Stockholm and at the Uppsala University, we generated a quantitative proteo...